BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12939528)

  • 1. Inhibition of agonist-induced positive inotropy by a selective Rho-associated kinase inhibitor, Y-27632.
    Nishimaru K; Tanaka Y; Tanaka H; Shigenobu K
    J Pharmacol Sci; 2003 Aug; 92(4):424-7. PubMed ID: 12939528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibition by the Rho kinase inhibitor Y-27632 of the increases in contractility and Ca2+ transients induced by endothelin-1 in rabbit ventricular myocytes.
    Chu L; Norota I; Endoh M
    Naunyn Schmiedebergs Arch Pharmacol; 2005 Mar; 371(3):185-94. PubMed ID: 15900512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of Rho-kinase (ROCK-2) expression and enhanced contraction to endothelin-1 in the mesenteric artery from lipopolysaccharide-treated rats.
    Büyükafşar K; Arikan O; Ark M; Kubat H; Ozveren E
    Eur J Pharmacol; 2004 Sep; 498(1-3):211-7. PubMed ID: 15363997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac effects of a selective rho-associated kinase inhibitor, Y-27632, assessed in canine isolated, blood-perfused heart preparations.
    Sugiyama A; Yatomi Y; Takahara A; Satoh Y; Hashimoto K
    Jpn J Pharmacol; 2002 Mar; 88(3):359-61. PubMed ID: 11949893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Rho-kinase in human gallbladder contractions.
    Büyükafşar K; Akça T; Nalan Tiftik R; Sahan-Firat S; Aydin S
    Eur J Pharmacol; 2006 Jul; 540(1-3):162-7. PubMed ID: 16730697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho-kinase (ROCK-1 and ROCK-2) upregulation in oleic acid-induced lung injury and its restoration by Y-27632.
    Köksel O; Yildirim C; Tiftik RN; Kubat H; Tamer L; Cinel L; Kaplan MB; Değirmenci U; Ozdülger A; Büyükafşar K
    Eur J Pharmacol; 2005 Mar; 510(1-2):135-42. PubMed ID: 15740734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
    Ishizaki T; Uehata M; Tamechika I; Keel J; Nonomura K; Maekawa M; Narumiya S
    Mol Pharmacol; 2000 May; 57(5):976-83. PubMed ID: 10779382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Rho-kinase (ROCK-1 and ROCK-2) and its substantial role in the contractile activity of the sheep ureter.
    Levent A; Büyükafsar K
    Br J Pharmacol; 2004 Oct; 143(3):431-7. PubMed ID: 15351780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Y-27632, a Rho-kinase inhibitor, inhibits proliferation and adrenergic contraction of prostatic smooth muscle cells.
    Rees RW; Foxwell NA; Ralph DJ; Kell PD; Moncada S; Cellek S
    J Urol; 2003 Dec; 170(6 Pt 1):2517-22. PubMed ID: 14634463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Rho-kinase inhibitor, Y-27632, reduces cholinergic contraction but not neurotransmitter release.
    Fernandes L; D'Aprile A; Self G; McGuire M; Sew T; Henry P; Goldie R
    Eur J Pharmacol; 2006 Nov; 550(1-3):155-61. PubMed ID: 17010334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha(1)-AR-induced positive inotropic response in heart is dependent on myosin light chain phosphorylation.
    Andersen GØ; Qvigstad E; Schiander I; Aass H; Osnes JB; Skomedal T
    Am J Physiol Heart Circ Physiol; 2002 Oct; 283(4):H1471-80. PubMed ID: 12234799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of contractility in rat epididymal vas deferens by Rho kinase inhibitors.
    Amobi NI; Chung IP; Smith IC
    Auton Autacoid Pharmacol; 2006 Apr; 26(2):169-81. PubMed ID: 16553645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Y-27632 potentiates relaxant effects of beta 2-adrenoceptor agonists in bovine tracheal smooth muscle.
    Nakahara T; Moriuchi H; Yunoki M; Sakamato K; Ishii K
    Eur J Pharmacol; 2000 Feb; 389(1):103-6. PubMed ID: 10686302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupation of the prostaglandin E2-type 1 receptor increases rat atrial contractility via a Y-27632-sensitive pathway.
    Wolkowicz PE; Ku DD; Grenett HE; Urthaler F
    Prostaglandins Other Lipid Mediat; 2002 Sep; 70(1-2):91-105. PubMed ID: 12428681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Y-27632 on acetylcholine-induced contraction of intact and permeabilized intrapulmonary bronchial smooth muscles in rats.
    Chiba Y; Takeyama H; Sakai H; Misawa M
    Eur J Pharmacol; 2001 Sep; 427(1):77-82. PubMed ID: 11553366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of Rho/Rho-kinase system in regulation of vascular smooth muscle contraction in tachycardia-induced heart failure.
    Hisaoka T; Yano M; Ohkusa T; Suetsugu M; Ono K; Kohno M; Yamada J; Kobayashi S; Kohno M; Matsuzaki M
    Cardiovasc Res; 2001 Feb; 49(2):319-29. PubMed ID: 11164842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacological analysis of Rho-kinase inhibitors and identification of molecular components of Ca2+ sensitization in the rat lower urinary tract.
    Teixeira CE; Jin L; Priviero FB; Ying Z; Webb RC
    Biochem Pharmacol; 2007 Aug; 74(4):647-58. PubMed ID: 17603024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relaxation of contracted rabbit tracheal and human bronchial smooth muscle by Y-27632 through inhibition of Ca2+ sensitization.
    Yoshii A; Iizuka K; Dobashi K; Horie T; Harada T; Nakazawa T; Mori M
    Am J Respir Cell Mol Biol; 1999 Jun; 20(6):1190-200. PubMed ID: 10340938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho-kinase inhibitor, Y-27632, has an antinociceptive effect in mice.
    Büyükafşar K; Yalçin I; Kurt AH; Tiftik RN; Sahan-Firat S; Aksu F
    Eur J Pharmacol; 2006 Jul; 541(1-2):49-52. PubMed ID: 16750189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of reduced sensitivity to Ca in beta-adrenergic action on airway smooth muscle.
    Oguma T; Kume H; Ito S; Takeda N; Honjo H; Kodama I; Shimokata K; Kamiya K
    Clin Exp Allergy; 2006 Feb; 36(2):183-91. PubMed ID: 16433855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.